For TIKOSYN info, please select from the following:
Become a Confirmed Prescriber
Patients
Become a Confirmed
Hospital
Become a T.I.P.S.™ Enrolled Pharmacy
Information, Education and Support
For more information please call 1-877-TIKOSYN
For additional website resources, please click here.
TIKOSYN is indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm.
TIKOSYN is indicated for the conversion of atrial fibrillation/atrial flutter to normal sinus rhythm.
TIKOSYN is indicated for the conversion of atrial fibrillation/atrial flutter to normal sinus rhythm.
To minimize the risk of induced arrhythmia, patients initiated or re-initiated on dofetilide should be placed for a minimum of 3 days in a facility that can provide calculations of creatinine clearance, continuous electrocardiographic monitoring, and cardiac resuscitation. For detailed instructions regarding dose selection, see DOSAGE AND ADMINISTRATION. TIKOSYN is available only to hospitals and prescribers who have received appropriate TIKOSYN dosing and treatment initiation education (see Dosing and Administration Section). For full Prescribing information, please click here.
The product information in this site is intended for residents of the United States only.